AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER
Jun 272016
 

Tabalumab

 

タバルマブ(遺伝子組換え)
Tabalumab (Genetical Recombination)

[1143503-67-6]

Tabalumab (LY 2127399) is an anti-B-cell activating factor (BAFF) human monoclonal antibody designed for the treatment of autoimmune diseases and B cell malignancies.[1][2] Tabalumab was developed by Eli Lilly and Company.

A phase III clinical trial for rheumatoid arthritis was halted in Feb 2013.[3] In September 2014, a second phase III trial focussing on treating systemic lupus erythematosus, was terminated early as the study failed to meet its primary endpoint.[4]

 

References

 

 

abalumab
Monoclonal antibody
Type Whole antibody
Source Human
Target BAFF
Identifiers
CAS Number 1143503-67-6 
ATC code none
ChemSpider none
Chemical data
Formula C6518H10008N1724O2032S38
Molar mass 146.25 kg/mol

////////////タバルマブ ,  遺伝子組換え, Tabalumab, 1143503-67-6, antibody, Monoclonal antibody

Share

Sorry, the comment form is closed at this time.

Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: